• Corpus ID: 2677435

The Efficacy of Antiviral Components from Plant Products against Herpes Simplex Virus Type 1

@inproceedings{Qavi2015TheEO,
  title={The Efficacy of Antiviral Components from Plant Products against Herpes Simplex Virus Type 1},
  author={Hamida B. Qavi},
  year={2015}
}
HSV-1 is the leading transmittable cause of blindness in the United State and the developed countries of the world. HSV-1 establishes lifelong latency in the TG and is associated with high morbidity and mortality in humans worldwide. Currently, there is no method available to eliminate latent HSV-1 from an infected individual. Several FDA approved anti-HSV-1 drugs, such as Acyclovir, Valancyclovir, Famcyclovir and Pencyclovir are available for treatment. However, widespread use of these… 

Tables from this paper

Anti-HSV-1 and hepatoprotective activities of the Soft coral Sarcophyton acutum from the red sea

Context: Herpes simplex virus type 1 (HSV-1) is one of the most common contagious viruses of the family herpesviridae. It produces infections ranging from painful skin ulcers, corneal damage to

Potential Synergistic Action of Bioactive Compounds from Plant Extracts against Skin Infecting Microorganisms

The present study describes the impact of plant extracts on the modulation of skin immunity, and their antimicrobial effects against selected skin invaders.

References

SHOWING 1-10 OF 31 REFERENCES

Ethnomedicines for the development of anti-herpesvirus agents

The Herpesviruses are important human pathogens that can cause mild to severe lifelong infections with high morbidity. Moreover, Herpes simplex virus type 2 (HSV-2) has been reported to be

Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.

  • P. Reusser
  • Medicine, Biology
    The Journal of hospital infection
  • 1996

New therapeutic approaches to the alphaherpesvirus infections.

The character of diseases caused by alphaherpesviruses has changed over the last decade and the frequency of acyclovir resistance has increased with the increase in the number of immunocompromised patients.

Ethnomedicines and ethnomedicinal phytophores against herpesviruses.

Antiviral therapy of HSV-1 and -2

The discovery of effective antiviral agents has been facilitated by advances in the fields of molecular biology and virology, which led to the development of safe and effective antivirals.

Screening for Antiviral Activities of Isolated Compounds from Essential Oils

Results indicate that phenylpropanoids and sesquiterpenes present in essential oils contribute to their antiviral activity against HSV.

Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research

It is important to evaluate the impact of vaccination on HSV-2 infection, clinically apparent genital herpes, and HSV shedding among vaccine recipients who acquire infection.

Efficacy results of a trial of a herpes simplex vaccine.

In a study population that was representative of the general population of HSV-1- and HSv-2-seronegative women, the investigational vaccine was effective in preventing HSV -1 genital disease and infection but not in preventingHSV-2 disease or infection.

Antiviral activity of the Indian medicinal plant extract Swertia chirata against herpes simplex viruses: a study by in-vitro and molecular approach.

In this preliminary study, the Indian medicinal plant extract, Swertia chirata showed antiviral properties against Herpes simplex virus type-1.

Anti-herpes simplex virus activity of alkaloids isolated from Stephania cepharantha.

FK-3000 was found to be a promising candidate as an anti-HSV agent against HSV-1, acyclovir resistant-type HSV -1 and HSv-2 with in vitro therapeutic indices of 90, 71 and 81, respectively.